Absci to participate in the morgan stanley 2nd annual biotechnology ai summit

Vancouver, wash. and new york, june 15, 2023 (globe newswire) -- absci corporation (nasdaq: absi), a generative ai drug creation company, today announced the company will be participating in the upcoming morgan stanley 2nd annual biotechnology ai summit in new york, ny.
ABSI Ratings Summary
ABSI Quant Ranking